Two-Year Drug Survival Of Dupilumab In A Large Cohort Of Difficult-To-Treat Adult Atopic Dermatitis Patients Compared To Cyclosporine A And Methotrexate: Results From The Bioday Registry

ALLERGY(2020)

引用 26|浏览6
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要